Insights from Digital Pharma Leaders
Refine Search
Biotechnology
This week, we discuss a novel AI-driven approach to drug development, and its potential to transform the treatment of cancer and autoimmune diseases. 14 November 2024
Pharmaceutical
Digital therapeutics company GAIA has announced the signing of a licensing agreement for attexis with fellow German firm MEDICE Arzneimittel Pütter. 14 November 2024
Biotechnology
Privately-held Boston-based biopharma FogPharma has announced a name change and unveiled a new AI-based platform. 11 November 2024
Pharmaceutical
A review has found that complexities and inefficiencies within the UK’s health data infrastructure are hindering the effective use of these resources that are critical for improving people’s health. 8 November 2024
Pharmaceutical
An Expert View from Nick Petschek, Managing Director EMEA, Kotter International. 18 October 2024
Pharmaceutical
California-based AI company Suki has raised $70 million in new funding to accelerate the growth of its AI-powered voice solutions in healthcare. 11 October 2024
Pharmaceutical
Machine learning-enabled drug discovery and development company insitro has announced the execution of three strategic agreements with Eli Lilly. 10 October 2024
Biotechnology
China’s Quantum Pharmaceuticals has announced a significant licensing agreement between its biologics-focused subsidiary, Ailux Biologics, and Johnson & Johnson. 10 October 2024
Pharmaceutical
The UK has launched a new Regulatory Innovation Office (RIO), with the goal of accelerating new technologies, particularly in sectors like biotech and healthcare, by reducing regulatory barriers. 9 October 2024
Biotechnology
British biotech IMU Biosciences has announced key changes to its leadership team as it looks to grow in the field of precision medicine. 17 September 2024
Biotechnology
Californian companies Gilead Sciences and Genesis Therapeutics have entered into a strategic collaboration to discover and develop novel, small molecule therapies across multiple targets. 10 September 2024
Biotechnology
ZipBio, a newly launched start-up based in Seattle, USA, is aiming to set a new standard in the development of biologics and gene therapies by utilizing generative AI technology. 9 September 2024
Pharmaceutical
An Expert View from Vikas Krishan, chief digital business officer at Altimetrik. 4 September 2024
Pharmaceutical
Otsuka Pharmaceuticals says that its subsidiaries Otsuka Precision Health, Inc. (OPH) and Click Therapeutics (Click) have launched Rejoyn (developed as CT-152). 19 August 2024
Pharmaceutical
CytoReason’s $80 million venture round may not have been the biggest in July, but it is one of a growing number of investor bets on AI powered drug discovery this year. 7 August 2024
Pharmaceutical
California’s ReviR Therapeutics has completed a $30 million series A financing round, bringing its total funding to $54 million. 29 July 2024
Pharmaceutical
An Expert View from Brendan Frey, founder and chief innovation officer of Deep Genomics. 4 July 2024
Biotechnology
AI-focused start-up Formation Bio has raised $372 million in a series D financing. 27 June 2024
Pharmaceutical
A recent survey from IDC highlights that 49% of the pharmaceutical industry believes they have achieved success in implementing artificial intelligence (AI) across the entire pharmacovigilance (PV) value chain. However, over the next two years, the industry expects this number to only marginally shift to just 51%. 17 June 2024
Pharmaceutical
Supply chain imperatives are evolving from drug production and delivery that are limited in scope towards a versatile supply chain addressing the needs of multiple stakeholders (such as caregivers, patients and insurance companies). The traditional supply chain approach based on materials requirement planning has progressed to its limits. 17 September 2018
Pharmaceutical
Privately-held Ferring Pharmaceuticals has announced a genomics collaboration with a health-focused tech firm. 30 August 2018
Pharmaceutical
Making patients the owners of and beneficiaries from their own data will be key to making blockchain technology deliver for healthcare as a whole, according to the theory behind a network that could convert siloed information into a connected driver of better research and outcomes. 22 August 2018
Pharmaceutical
“The Russian pharma market is like a huge ocean. If you know who lives in the ocean and what sort of currents the ocean has, then it is all simple and understandable.” 10 August 2018
Pharmaceutical
Sanofi Ventures, the investment arm of French pharma major Sanofi has entered into a $17 million deal with New York-based Click Therapeutics. 23 July 2018
Pharmaceutical
For several years, pharma analysts have predicted varying degrees of impact from nascent blockchain technologies. While some suggest wholesale revolution is in the offing, others anticipate more incremental evolution for a conservative industry that is traditionally resistant to change. 23 July 2018
Pharmaceutical
The first applications of blockchain in healthcare will emerge in the supply chain, says GlobalData. 4 July 2018
Pharmaceutical
In the latest Expert View piece on artificial intelligence (AI), Christopher Bouton, founder and CEO of Vyasa, a provider of software for the life sciences and healthcare industries, analyzes what the future holds for biopharma in an AI-driven world. 9 May 2018
Biotechnology
Akili Interactive, a prescription digital medicine company developing novel treatments for cognitive dysfunction that was founded by London-listed biopharma company PureTech Health, is now $55 million better off following a financing round. 9 May 2018
Pharmaceutical
Ian Churcher, vice president of drug discovery at BenevolentAI, argues that pharma needs to embrace artificial intelligence (AI) to solve the issues which underlie the stagnation of drug discovery, in an Expert View piece. 27 April 2018
Pharmaceutical
The rising cost of drug development, growing need for medicines with an aging population and the greater prevalence of chronic conditions, political uncertainty – many factors suggest that the problem of pricing drugs affordably is not about to away any time soon. 24 April 2018
Pharmaceutical
Mindful that integrating model-informed drug development (MIDD) into more drug applications and advancing its use are US Food and Drug Administration’s (FDA) goals under the Prescription Drug User Fee Amendments of 2017, the agency has stepped up its publicizing of the potential benefits to drugmakers. 20 April 2018
Pharmaceutical
Business, technical, and financial incentives are driving the rapid adoption of cloud-based, commercially available solutions in pharmaceutical research and operations, writes Frank Lin, consultant at Halloran Consulting Group, in an Expert View piece. 27 March 2018
Pharmaceutical
Deals with tech companies are almost seen as essential in pharma today as they consider how to combat challenges such as rising development costs, but rarely is the need for these collaborations spelt out so clearly as it was when two Japanese firms announced a collaboration on Monday. 26 March 2018
Pharmaceutical
Harnessing digital technologies could unlock £22 billion ($30.1 billion) for UK pharma companies over the next decade, according to Accenture. 13 March 2018
Pharmaceutical
In the second of two Expert View columns to whet the appetite for the eyeforpharma Barcelona event in March, Sanofi’s Chief Data Officer (CDO), Milind Kamkolkar, expounds the possibilities of digital and the role of the CDO in this burgeoning landscape. 31 January 2018
Pharmaceutical
In a highly informative and useful Expert View piece, Heather Longden, senior marketing manager for informatics regulatory compliance at the analytical laboratory instrument and software company Waters Corporation, provides insights into the vital role data integrity plays when it comes to analytical testing for drug development. 26 January 2018
Pharmaceutical
Andrew Rut, chief executive of MyMeds&Me, a provider of adverse event and product quality capture software, considers in an Expert View piece how pharma’s ability to run efficient clinical trials is in danger of being compromised by GDPR and a hardening of attitudes on data privacy globally. 9 January 2018
Pharmaceutical
German pharma major Boehringer Ingelheim has increased the size of its corporate venture fund to 250 million euros ($301 million). 3 January 2018
Pharmaceutical
In an area like oncology, innovation is needed not just with the end product, but in the way that researchers get there, finds Rik Van Mol, vice president of R&D strategy at software provider Veeva Systems, in an Expert View piece looking at a leading cancer charity’s modernization of clinical operations. 15 November 2017
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze